Web Stats Provided By Google Analytics

Thursday, May 2, 2013

Chembio: A Potentially Undervalued Diagnostics Biotech

Chembio Diagnostics Inc. is an undervalued biotechnology company that has a revolutionary patented Dual Path Platform Technology in its arsenal and will continue to use this asset to generate growth in the future.

http://seekingalpha.com/article/1394581-chembio-a-potentially-undervalued-diagnostics-biotech?source=feed

No comments:

Post a Comment